Supernus Pharmaceuticals reported $1.97M in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 2912M 376M
Aerie Pharmaceuticals AERI:US $ -33643000 85.38M
Ani Pharmaceuticals ANIP:US $ -19195000 1.8M
Aurora Cannabis Inc ACB:CN C$ -110537000 13M
Bristol Myers Squibb BMY:US $ 3188M 399M
Canopy Growth Corp WEED:CN -304230000 192.32M
Cara Therapeutics CARA:US $ -27911000 5.61M
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Eisai 4523:JP -20803000000 34.45B
Eli Lilly And LLY:US $ 2569.9M 171.6M
Endo International Ordinary Shares ENDP:US $ 120.25M 52.02M
Horizon Pharma HZNP:US 196.44M 99.18M
JAZZ PHA JAZZ:US 87.55M 105.43M
Lannett LCI:US $ -20301000 2.47M
Marinus Pharmaceuticals MRNS:US -16711000 10.4M
Pacira Pharmaceuticals PCRX:US $ 21.73M 24.09M
Perrigo Ordinary Shares PRGO:US $ 23.1M 39.7M
Revance Therapeutics RVNC:US $ -62221000 617K
Supernus Pharmaceuticals SUPN:US $ 1.97M 26.43M
Teva Pharmaceutical Industries TEVA:US 789M 182M
United Therapeutics UTHR:US $ 288M 117.2M
Xeris Pharmaceuticals Inc XERS:US $ -19074000 27M